MELISSA JACOBS: Open Payments
NPI 1114239100 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 56 payments from 17 companies in 2025. Trend: 2023 $2,219 · 2024 $1,219 · 2025 $1,309
Food & beverage: $1,304Education: $5
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 20 | $220 |
| ABBVIE INC. | 8 | $182 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| Myriad Genetic Laboratories, Inc. | 4 | $126 |
| Procept Biorobotics Corporation | 1 | $102 |
| 180 Medical, Inc. | 2 | $93 |
| Teleflex LLC | 2 | $70 |
| Endo USA, Inc. | 3 | $62 |
| Antares Pharma, Inc. | 3 | $51 |
| BIOPROTECT MEDICAL, INC. | 2 | $49 |
Products named: GEMTESA, BOTOX, VOQUEZNA, PROLARIS, AQUABEAM ROBOTIC SYSTEM, UROLIFT, XIAFLEX, XYOSTED.
Industry payments across TX — which companies pay providers there.
